Medicines Containing The Active Ingredient Rituximab - In The Dosage Form Concentrate For Infusion Solution (Atc: L01Fa01)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 97538127

  Document Type - Tender Notices

Description - Description: The subject of this publication is the conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the Social Code Book V for finished medicinal products containing the active ingredient rituximab - in the dos age form of infusion solution concentrate (ATC: L01FA01) within the framework of a so-called "open-house model". Under the specification of uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or groups of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the aforementioned a

Mt Ref Id - 97538127

Deadline - Oct 31, 2026